AHN-GOOK PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,580 KRW | +0.26% |
|
+0.80% | -19.45% |
| Sales 2022 | 205B 149M 205M | Sales 2023 | 234B 169M 233M | Capitalization | 107B 77.54M 107M |
|---|---|---|---|---|---|
| Net income 2022 | 6.88B 4.98M 6.86M | Net income 2023 | 1.29B 935K 1.29M | EV / Sales 2022 | 0.42 x |
| Net cash position 2022 | 18.44B 13.37M 18.4M | Net cash position 2023 | 17.77B 12.88M 17.73M | EV / Sales 2023 | 0.38 x |
| P/E ratio 2022 |
15.2
x | P/E ratio 2023 |
82.9
x | Employees | 376 |
| Yield 2022 |
2.39% | Yield 2023 |
2.34% | Free-Float | 38.16% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.26% | ||
| 1 week | +0.80% | ||
| Current month | +0.80% | ||
| 1 month | -0.92% | ||
| 3 months | -2.32% | ||
| 6 months | -9.65% | ||
| Current year | -19.45% |
1 week
7 490.00
7 630.00
1 month
7 410.007 940.00
Current year
7 390.0010 160.00
1 year
7 150.0010 510.00
3 years
7 140.0015 000.00
5 years
6 300.0020 650.00
10 years
6 300.0034 250.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Oh
CEO | Chief Executive Officer | 60 | - |
Jun-Sun Oh
CEO | Chief Executive Officer | 87 | - |
Deok-Gwon Won
PSD | President | 60 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun-Sun Oh
CEO | Chief Executive Officer | 87 | - |
Jin Oh
CEO | Chief Executive Officer | 60 | - |
Deok-Gwon Won
PSD | President | 60 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 7,580 | +0.26% | 11,005 |
| 24-06-05 | 7,560 | 0.00% | 11,223 |
| 24-06-04 | 7,560 | -0.53% | 20,296 |
| 24-06-03 | 7,600 | +1.06% | 22,007 |
| 24-05-31 | 7,520 | +0.67% | 112,316 |
End-of-day quote Korea S.E., June 06, 2024
More quotes
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -19.45% | 62.52M | |
| +19.64% | 43.3B | |
| +21.25% | 22.22B | |
| +18.92% | 15.43B | |
| +20.14% | 14.48B | |
| +53.19% | 12.72B | |
| -0.05% | 6.79B | |
| -11.11% | 6.71B | |
| -8.87% | 5.73B | |
| +14.68% | 5.5B |
- Stock Market
- Equities
- A001540 Stock
